temozolomide has been researched along with at 13387 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abas, FS; Beattie, CE; Canella, A; Gumin, J; Gurcan, MN; Kaur, B; Kesanakurti, D; Lang, FF; Liu, J; Nagarajan, P; Puduvalli, VK; Sampath, D; Sulman, EP; Welker, AM; Xu, J; Yoo, JY | 1 |
| Beattie, CE; Canella, A; Easley, M; Elder, JB; Jacob, NK; Lai, TH; Lang, F; Lonser, R; Pietrzak, M; Puduvalli, VK; Sampath, D; Sharma, P; Timmers, CM; Welker, AM; Wu, PJ; Xu, J | 1 |
2 other study(ies) available for temozolomide and at 13387
| Article | Year |
|---|---|
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas.
Topics: Animals; Antineoplastic Agents; Benzamides; Blood-Brain Barrier; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dacarbazine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Glioma; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Mice; Neoplastic Stem Cells; Protein Transport; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases; Signal Transduction; Survival Rate; Temozolomide; Xenograft Model Antitumor Assays; Zebrafish | 2017 |
Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation Therapy.
Topics: Animals; Antineoplastic Agents; Benzamides; Brain Neoplasms; Cell Line, Tumor; DNA Repair; Glioblastoma; Glioma; Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Mice; Temozolomide; Xenograft Model Antitumor Assays; Zebrafish | 2022 |